About this trial
The purpose of the study is to see examine the effects of 3 different levels of physical activity (45 minutes/week, 90 minutes/week, or 150 minutes/week) on arthritis symptoms.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 years or older
Have a doctor diagnosed form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia
Ability to read and write in English
Disqualifiers
Have any contraindications to exercise (besides arthritis)
Engage in >45 min/week of Actigraph assessed moderate to vigorous intensity activity
Are pregnant, breastfeeding, or planning to become pregnant in the next year
Are planning to relocate out of the Columbia, SC area in the next 12 months,
Trial design
Parallel
Treatments tested in this trial
DREAM Adaptive Intervention
Behavioral6-month physical activity program (Dose Response of Exercise for Arthritis Management (DREAM)) which includes monthly phone coaching, Walk With Ease Guidebook, behavioral lessons, and a Fitbit. Participants may receive additional contact (email, text, or phone) if they struggle to meet activity goal.
Treatment groups
Trial outcomes
Primary outcomes
Physical function (6 Minute Walk Test)
Change in distance walked during the 6 minute walk test
Secondary outcomes
Physical function (6 Minute Walk Test)
Change in distance walked during the 6 minute walk test
Physical function (chair stands)
Change in chair stand repetitions
Physical function (chair stands)
Change in chair stand repetitions
Health Related Quality of Life - Physical
Change in the physical component score of the SF-12v2 Health Survey. Scores range from 0-100, with higher scores reflective of better health.
Other outcomes
Physical activity (min/week)
Change in Actigraph-assessed moderate-to-vigorous intensity physical activity
Physical activity (min/week)
Change in Actigraph-assessed moderate-to-vigorous intensity physical activity
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of South Carolina
Lead sponsor
Centers for Disease Control and Prevention
Collaborator